People who develop Parkinson’s disease before age 50 may have been born with disordered brain cells that went undetected for decades, according to new research. The research points to a drug that potentially might help correct these disease processes.
A new substance named Lu AF60097 may help reduce side effects from tricyclic antidepressants in those with severe depression.
Researchers have uncovered a key role of medial prefrontal cortex corticotropin-releasing factor interneurons for bidirectionally controlling motivated behavioral styles under stress. The findings could help in the development of new treatments for PTSD.
MIT researchers have identified a protein fragment that may inhibit COVID-19’s ability to enter human lung cells.
Researchers have developed a new method to record brain activity at scale. The new technique could help in the development of new neuroprosthetic devices to help amputees and those with movement restricting neurological conditions.
New research suggests that eye movements may come before hand movements in actions that require a two-step decision-making process.
A new method to accurately record brain activity at scale has been developed by researchers. The technique could lead to new medical devices to help amputees, people with paralysis or people with neurological conditions such as motor neuron disease.
Stress, loneliness, and sleep loss can weaken the immune system, leaving people more susceptible to COVID-19.
Finally this week. using robotics, researchers have uncovered mechanisms in the cerebellum and spinal cord that determine how the nervous system responds to induced changes in step length. The findings could have implications for physical rehabilitation programs for people with movement disorders.